Novel polymorphism in the promoter region of the tumor necrosis factor alpha gene: No association with narcolepsy

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 88, Issue 4, 1999, Pages 301-304

  Kato, Tadafumi ^a   Honda, Makoto ^b   Kuwata, Shouji ^c   Juji, Takeo ^d   Kunugi, Hiroshi ^e   Nanko, Shinichiro ^e   Fukuda, Masato ^a   Honda, Yutaka ^f  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

^f NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

Author keywords

Cytokines; Human leukocyte antigens (HLA); Molecular genetics; Sleep disorders

Indexed keywords

HLA DR2 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NARCOLEPSY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; GENOTYPE; HUMANS; NARCOLEPSY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033588247     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990820)88:4<301::AID-AJMG4>3.0.CO;2-3     Document Type: Article

References (28)

1. Bassam BJ, Caetano-Anolles G, Gresshoff PM. 1991. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 196:80-83.
2. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P. 1996. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha. (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci Lett 215:75-78.
3. Breder CD, Tsujimoto M, Terano Y, Sctoo DW, Saper CB. 1993. Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system. J Comp Neurol 337:543-567.
4. D'Alfonso S, Colombo G, Delia Bella S, Scorza R, Momigliano-Richiardi P. 1996. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 47:551-555.
5. Diagnostic Classification Steering Committee. 1990. ICSD-International classification of sleep disorders: Diagnostic and coding manual. Rochester, Minn.: American Sleep Disorders Association.
6. Ellis MC, Hetisimer AH, Ruddy DA, Hansen SL, Kronmal GS. 1997. HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy. Immunogeneics 46:410-417.
7. Fang J, Wang Y, Krueger JM. 1997. Mice lacking the TNF 55 kDa receptor fail to sleep more after TNF α treatment. J Neurosci 17:5949-5955.
8. Honda Y, Doi Y, Juji T, Satake M. 1984. Narcolepsy and HLA: positive DR2 as a prerequisite for the development of narcolepsy. Folia Psychiatr Neurol Jpn (abstract) 38:360.
9. Honda Y, Juji T. 1988. HLA in narcolepsy. Springer-Verlag.
10. Honda Y, Juji T, Matsuki K, et al. 1986. HLA-DR2 and Dw 2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. Sleep 9:133-142.
11. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans A, Breedveld FC, Verweij CL, van de Gaer L, Dams L, Crusius JB, Garcia-Gonzalez A, van Oosten BW, Polman CH, Pena AS. 1997. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72:149-153.
12. Jongeneel CV. 1994. Regulation of the TNF α gene. Prog Clin Biol Res 388:367-381.
13. Juji T, Satake M, Honda Y, et al. 1984. HLA antigens in Japanese patients with narcolepsy: all the patients were DR2 positive. Tissue Antigens 24:316-319.
14. Kanbayashi T, Nishino S, Tafti M, Hishikawa Y, Dement WC, Mignot E. 1996. Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy. Neuroreport 7:1881-1886.
15. Kapas L, Hong L, Cady AB, Opp MR. 1992. Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-α and TNF α fragments. Am Physiological Soc 263:R708-715.
16. Krueger JM, Majde JA. 1995. Cytokines and sleep. Int Arch Allergy Immunol 106:97-100.
17. Kuwata S, Juji T, Sasaki T, et al. 1992. HLA 1991, proceedings of the 11th International Histocompatibility Workshop and Conference, vol. 2. Oxford, p 730-732.
18. McGuire W, Hill AV, Allsopp CE, Greenwood, Kwiatkowski D. 1994. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508-510.
19. Mignot E, Kimura A, Lattermann A, Lin X, Yasunaga S, Mueller-Eckhardt G, Rattazzi C, Lin L, Guilleminault C, Grumet FC, Mayer G, Dement WC, Underhill P. 1997. Extensive HLA class II studies in 58 nonDRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 49: 329-341.
20. Nadel S, Newport MJ, Booy R, Levin M. 1996. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174:878-880.
21. Orita M, Suzuki Y, Sekiya T, Hayashi K. 1989. Rapid and sensitive detection of point mutation and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879.
22. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM. 1995. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 42:501-504.
23. Rink L, Kirchner H. 1996. Recent progress in the tumor necrosis factor-alpha field. Int Arch Allergy Immunol 111:199-209.
24. Rogers AE, Meehan J, Guilleminault C, Grumet FC, Mignot E. 1997. HLA DR15 (DR2) and DQB1 *0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology 48:1550-1556.
25. Shoham S, Davenne D, Cady AB, Dinarello CA, Krueger JM. 1987. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 253:R142-R149.
26. Takahashi S, Kapas L, Fang J, Krueger JM. 1995. An anti-tumor necrosis factor antibody suppresses sleep in rats and rabbits. Brain Res 690:241-244.
27. Takashiba S, Shapira L, Amar S, Van Dyke TE. 1993. Cloning and characterization of human TNF α promoter region. Gene 131:307-308.
28. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. 1997. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313-1316.